It was indeed how Mesut Ozil changed the course of game between Real Madrid and Borussia Dortmund ending in a draw 2-2. With the result, there are chances of Real Madrid to enter the Champions League knockout round as Group D winners.
It was seen how Cristiano Ronaldo left it to Ozil to kick the last goal in the 89th minute, thereby leaving no chance for Dortmund keeper Roman Weidenfeller to do anything. It has been further reported that this draw would make Dortmund top on eight points as they have played four of their six group matches, while Real second of seven, leading from Ajax Amsterdam (four) and Manchester City (two).
"They have a great team and everything is still open so we have to keep working", said Pepe, whose goal was his third only in Europe's elite club competition. "We played well in the second half".
It has been said Cristiano Ronaldo, who is top scorer in Europe's elite club competition this season, didn't do much, though he managed to get a strong reaction from Weidenfeller just over 10 minutes from time.
Nonetheless, what Ozil, who is playing with many of the Dortmund side for Germany, did yesterday has left a mark on one and all.
According to a post published to Microsoft’s official blog on Wednesday, the number of devices running the company’s latest Windows version -- the Windows 10 operating system -- has touched 350 million.
The new milestone in the Windows 10...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
The Verge has revealed in a Wednesday report, citing a statement released by Lexus, that the working of the head units of a number of vehicles has been affected because of an over-the-air (OTA) update recently rolled out by the company.
...
The drought conditions in California is widening economic split in California. The prospect of...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
A panel of US medical experts said that there is no...
At the GSMA Mobile World Congress in Shanghai, HTV Vive...
According to a post published to Microsoft’s official...
No matter how dangerous a task it seems to look within a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).